FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160539237> ?p ?o ?g. }

• W2160539237 endingPage "227" @default.
• W2160539237 startingPage "223" @default.
• W2160539237 abstract "ABSTRACT To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a multiple-dose, three-period, placebo-controlled, crossover study. Patients were randomly assigned to receive indinavir at 1,000 mg every 8 h for 7 <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML display=inline overflow=scroll> <mml:mfrac> <mml:mrow> <mml:mn>1</mml:mn> </mml:mrow> <mml:mrow> <mml:mn>3</mml:mn> </mml:mrow> </mml:mfrac> </mml:math> days (with fluconazole placebo), fluconazole at 400 mg once daily for 8 days (with indinavir placebo), and indinavir with fluconazole in combination. The pharmacokinetics of both drugs were measured on day 8 of each treatment period. The peak concentration in plasma ( C max ) and the time to reach C max were obtained by inspection, and the area under curve (AUC) was calculated for indinavir and fluconazole for each treatment period in which the respective drugs were administered. There was a marginally ( P = 0.08) statistically significant decrease in the AUC from 0 to 8 h (AUC 0–8 ) for indinavir when it was administered with fluconazole. However, the magnitudes of the decreases in C max and the concentration at 8 h postdosing ( C 8 ) were not as great as the decrease in AUC 0–8 . Although the 90% confidence interval for the geometric mean ratio was within the hypothesized limits, the clinical significance is not clear. Indinavir coadministration with fluconazole had no statistically ( P > 0.5) or clinically significant effect on the C max and C 8 of indinavir. Fluconazole coadministration with indinavir had no statistically or clinically significant effect on the pharmacokinetics of fluconazole. One patient was discontinued because of mild to moderate abdominal pain and diarrhea while on indinavir and fluconazole in combination. No serious adverse experience according to the results of laboratory tests was noted. Total bilirubin levels in serum were mildly increased in most patients treated with indinavir. This was not clinically significant and was not affected by the coadministration of fluconazole. Although the values of the pharmacokinetic parameters for indinavir decrease in the presence of fluconazole, indinavir and fluconazole can be administered concomitantly to HIV-infected patients without adjustment of the dose of either drug, and both drugs are generally well tolerated." @default.
• W2160539237 created "2016-06-24" @default.
• W2160539237 creator A5024807342 @default.
• W2160539237 creator A5037870737 @default.
• W2160539237 creator A5038076269 @default.
• W2160539237 creator A5042823176 @default.
• W2160539237 creator A5053083823 @default.
• W2160539237 creator A5060019163 @default.
• W2160539237 creator A5061133224 @default.
• W2160539237 creator A5061401383 @default.
• W2160539237 creator A5083730478 @default.
• W2160539237 date "1998-02-01" @default.
• W2160539237 modified "2023-09-23" @default.
• W2160539237 title "Effect of Fluconazole on Indinavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Patients" @default.
• W2160539237 cites W1971920484 @default.
• W2160539237 cites W1998575185 @default.
• W2160539237 cites W2022869105 @default.
• W2160539237 cites W2064712711 @default.
• W2160539237 doi "https://doi.org/10.1128/aac.42.2.223" @default.
• W2160539237 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/105391" @default.
• W2160539237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9527763" @default.
• W2160539237 hasPublicationYear "1998" @default.
• W2160539237 type Work @default.
• W2160539237 sameAs 2160539237 @default.
• W2160539237 citedByCount "26" @default.
• W2160539237 countsByYear W21605392372018 @default.
• W2160539237 countsByYear W21605392372020 @default.
• W2160539237 crossrefType "journal-article" @default.
• W2160539237 hasAuthorship W2160539237A5024807342 @default.
• W2160539237 hasAuthorship W2160539237A5037870737 @default.
• W2160539237 hasAuthorship W2160539237A5038076269 @default.
• W2160539237 hasAuthorship W2160539237A5042823176 @default.
• W2160539237 hasAuthorship W2160539237A5053083823 @default.
• W2160539237 hasAuthorship W2160539237A5060019163 @default.
• W2160539237 hasAuthorship W2160539237A5061133224 @default.
• W2160539237 hasAuthorship W2160539237A5061401383 @default.
• W2160539237 hasAuthorship W2160539237A5083730478 @default.
• W2160539237 hasBestOaLocation W21605392372 @default.
• W2160539237 hasConcept C112705442 @default.
• W2160539237 hasConcept C126322002 @default.
• W2160539237 hasConcept C142724271 @default.
• W2160539237 hasConcept C159047783 @default.
• W2160539237 hasConcept C16005928 @default.
• W2160539237 hasConcept C185592680 @default.
• W2160539237 hasConcept C204787440 @default.
• W2160539237 hasConcept C27081682 @default.
• W2160539237 hasConcept C2776452011 @default.
• W2160539237 hasConcept C2777210460 @default.
• W2160539237 hasConcept C2779548794 @default.
• W2160539237 hasConcept C2780651595 @default.
• W2160539237 hasConcept C2780727368 @default.
• W2160539237 hasConcept C3013748606 @default.
• W2160539237 hasConcept C44249647 @default.
• W2160539237 hasConcept C71924100 @default.
• W2160539237 hasConcept C76318530 @default.
• W2160539237 hasConcept C87813604 @default.
• W2160539237 hasConcept C98274493 @default.
• W2160539237 hasConceptScore W2160539237C112705442 @default.
• W2160539237 hasConceptScore W2160539237C126322002 @default.
• W2160539237 hasConceptScore W2160539237C142724271 @default.
• W2160539237 hasConceptScore W2160539237C159047783 @default.
• W2160539237 hasConceptScore W2160539237C16005928 @default.
• W2160539237 hasConceptScore W2160539237C185592680 @default.
• W2160539237 hasConceptScore W2160539237C204787440 @default.
• W2160539237 hasConceptScore W2160539237C27081682 @default.
• W2160539237 hasConceptScore W2160539237C2776452011 @default.
• W2160539237 hasConceptScore W2160539237C2777210460 @default.
• W2160539237 hasConceptScore W2160539237C2779548794 @default.
• W2160539237 hasConceptScore W2160539237C2780651595 @default.
• W2160539237 hasConceptScore W2160539237C2780727368 @default.
• W2160539237 hasConceptScore W2160539237C3013748606 @default.
• W2160539237 hasConceptScore W2160539237C44249647 @default.
• W2160539237 hasConceptScore W2160539237C71924100 @default.
• W2160539237 hasConceptScore W2160539237C76318530 @default.
• W2160539237 hasConceptScore W2160539237C87813604 @default.
• W2160539237 hasConceptScore W2160539237C98274493 @default.
• W2160539237 hasIssue "2" @default.
• W2160539237 hasLocation W21605392371 @default.
• W2160539237 hasLocation W21605392372 @default.
• W2160539237 hasLocation W21605392373 @default.
• W2160539237 hasOpenAccess W2160539237 @default.
• W2160539237 hasPrimaryLocation W21605392371 @default.
• W2160539237 hasRelatedWork W1984317973 @default.
• W2160539237 hasRelatedWork W1984562481 @default.
• W2160539237 hasRelatedWork W2025663121 @default.
• W2160539237 hasRelatedWork W2039491855 @default.
• W2160539237 hasRelatedWork W2056242922 @default.
• W2160539237 hasRelatedWork W2064230088 @default.
• W2160539237 hasRelatedWork W2080398286 @default.
• W2160539237 hasRelatedWork W2087795740 @default.
• W2160539237 hasRelatedWork W2369727719 @default.
• W2160539237 hasRelatedWork W3085943042 @default.
• W2160539237 hasVolume "42" @default.
• W2160539237 isParatext "false" @default.
• W2160539237 isRetracted "false" @default.
• W2160539237 magId "2160539237" @default.
• W2160539237 workType "article" @default.